Delivery Order SPE2DB24D1104-SPE2DB25FYDP8
- Not listed
- The Defense Logistics Agency awarded a $22,179.74 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Bridion is a pharmaceutical product used in medical settings, consistent with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a $12,008.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Bridion is a pharmaceutical reversal agent used in anesthesia recovery,...
- The Defense Logistics Agency awarded a delivery order valued at $1,677.58 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a small-value transaction for a pharmaceutical product commonly used in anesthesia and critical care settings. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,673.61 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a continuation of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,402.73 delivery order to AmerisourceBergen Drug Corp for Bridion 500 mg/5 ml vials on July 21, 2025, with a completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,822.12 contract is for the supply of Bridion 200 mg/2 ml vial medication, with a period of performance through May 14, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,717.47, is for the delivery of Bridion 200mg/2ml, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDP8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $2,082.27 under a firm fixed price arrangement. This is a non-set-aside competitive award with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. Bridion is a pharmaceutical product used in medical settings, and this delivery order represents a routine pharmaceutical procurement to support federal healthcare operations. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp's extensive portfolio of federal contracts demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and product categories for defense and healthcare agency customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/23/25 |